Activation of TSG-6 mediated the effect of BM-MSCs in myocardial infarction [40], cornea damage [41], and more recently peritoneal injury [42], via a common mechanism of inhibiting local inflammation and fibrosis. This evidence concerns the gene TNFAIP6 and myocardial infarction.